FIELD: vitamins.
SUBSTANCE: food, feed, fish processing, cosmetic and pharmaceutical industries. A composition based on vitamin E for lipid stabilization with a content of eicosapentaenoic and docosahexaenoic acids of at least 20% of the total fatty acids, containing vitamin E and a component that exhibits a synergistic effect, differs in that it contains vitamin E, which is used as α-tocopherol acetate, 2,2'-methylene-bis(4 methyl-6-tert-butylphenol) and salicylic acid, showing a synergistic effect, in the following ratio of components in the composition, wt.%: 2,2'-methylene-bis(4-methyl-6-tert-butylphenol) - 49.9-69.9;α -tocopherol acetate - 29.95-50.00; salicylic acid - 0.05-0.15. The composition is administered in an amount of 0.15-0.35 wt.% of lipids.
EFFECT: effective inhibition of lipid oxidation at a minimum concentration of components in the composition in comparison with their use separately.
1 cl, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION BASED ON AN ANTIOXIDANT OF NATURAL ORIGIN FOR LIPID STABILIZATION WITH A CONTENT OF EICOSAPENTAENOIC AND DOCOSAHEXAENOIC ACIDS OF AT LEAST 20% OF THE TOTAL FATTY ACIDS | 2023 |
|
RU2808593C1 |
VITAMIN E-BASED COMPOSITION FOR LIPID STABILIZATION CONTAINING EICOSAPENTAENOIC AND DOCOSAHEXAENOIC ACIDS AT LEAST 20% OF THE TOTAL FATTY ACIDS | 2023 |
|
RU2809329C1 |
COMPOSITION BASED ON AN ANTIOXIDANT OF NATURAL ORIGIN FOR LIPID STABILIZATION WITH A CONTENT OF EICOSAPENTAENOIC AND DOCOSAHEXAENOIC ACIDS OF AT LEAST 20% OF THE TOTAL FATTY ACIDS | 2023 |
|
RU2808594C1 |
METHOD FOR PREDICTING THREAT OF EARLY TERMINATION OF PREGNANCY DURING EXACERBATION OF CYTOMEGALOVIRUS INFECTION BY DETERMINING Α-TOCOPHEROL AND W-3 POLYUNSATURATED FATTY ACIDS IN BLOOD SERUM | 2021 |
|
RU2751650C1 |
OILS CONTAINING POLYUNSATURATED FATTY ACIDS RESISTANT TO OXIDATION | 2012 |
|
RU2738127C2 |
METHOD OF PRODUCING A BIOLOGICALLY ACTIVE ADDITIVE WITH POLY-SATURATED FATTY ACIDS | 2019 |
|
RU2716970C1 |
LIPID COMPOSITION WITH BALANCED FATTY ACID COMPOSITION AND COMPLEX OF BIOLOGICALLY ACTIVE COMPOUNDS (VERSIONS) | 2023 |
|
RU2818066C1 |
SPECIALIZED LIPID MODULE | 2014 |
|
RU2603583C2 |
METHOD FOR ARACHIDONIC ACID PRODUCTION | 2016 |
|
RU2627273C1 |
GRANULATE CONTAINING UNSATURATED FATTY ACIDS AND RESISTANT TO OXIDATION | 2007 |
|
RU2423867C2 |
Authors
Dates
2023-11-17—Published
2023-07-01—Filed